Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2003
06/26/2003WO2003020304A3 Inflammation modulatory compound comprising an endomorphin
06/26/2003WO2002046385A3 Enzymes
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119885 1,2-Diaminocyclopentanes, e.g., N-(2-(3-(4-chlorophenyl)-propylamino)cyclopentyl)-2-(5-(3,4 -dimethoxyphenyl)pyrimidin-2-ylsulfanyl)acetamide; inhibit eosinphil recruitment; skindisorders; asthma; antiinflammatory agents, antiallergens
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119859 Useful in the prophylaxis and treatment of respiratory diseases
06/26/2003US20030119847 Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119825 Highly concentrated stable meloxicam solutions for needleless injection
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119802 Use particularly in the prophylaxis and treatment of respiratory diseases.
06/26/2003US20030119797 Methods for selective immunomodulation
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119786 Combinations for the treatment of immunoinflammatory disorders
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470763A1 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003CA2470645A1 Streptococcus pneumoniae vaccine
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470210A1 Use of selective pde5 inhibitors for treating partial and global respiratory failure
06/26/2003CA2469950A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1321153A1 Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320361A1 Method for reducing exacerbations associated with copd
06/25/2003EP1320355A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
06/25/2003EP1283725A4 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
06/25/2003EP1283709A4 Peptide deformylase inhibitors
06/25/2003EP1250343B1 Azalide antibiotic compositions
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0679182B1 Delivery of gene products via mesangial cells
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426411A 3-(diarylmethylene)-8-azabicyclo [3,2,1] octane derivatives
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426305A Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract
06/25/2003CN1425459A Nose spray medicine
06/25/2003CN1425447A Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method
06/25/2003CN1425441A Compound macrostem onion preparation for curing chronic obstructive lung disease and its preparing method
06/25/2003CN1425427A Method for preparing cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet
06/25/2003CN1425426A Medicine for curing cold and influenza and complication and its preparing process
06/25/2003CN1425414A Rabdosia extract and its preparing method and use
06/25/2003CN1425413A Xiasangju effervescent tablet and its preparing process
06/25/2003CN1425405A Nasal medicine tablet for treating rhinitis
06/25/2003CN1425378A Composition for curing branchial asthma
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/25/2003CN1112204C Traditional Chinese powder medicine for treating cough and preparation process thereof
06/25/2003CN1112200C Chinese-medicinal nose drops for treating acute or chronic rhinitis and its preparing process
06/25/2003CN1112188C Nasal drops
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583283 Polymorphic forms of cipamfylline
06/24/2003US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583146 Thiazolopyrimidine compounds, its production and use
06/24/2003US6583143 CRF receptor antagonists and methods relating thereto
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003US6581773 Weight-specific elixir dosage calculator
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/19/2003WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer